Analysis of the therapeutic effect of posterior scleral constriction surgery on pathological myopic fundus lesions

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400089443

Enrollment

Unknown

Registered

2024-09-09

Start date

2023-06-13

Completion date

Unknown

Last updated

2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathological myopia

Interventions

Study group:Posterior scleral contraction

Eligibility

Sex/Gender

All

Age

6 Years to 100 Years

Inclusion criteria

Inclusion criteria: Eye axis>26.5mm, with an annual growth of 0.2mm, accompanied by macular hole, Retinal detachment, Choroid neovascularization, etc.

Exclusion criteria

Exclusion criteria: 1. Non axial myopia: such as curvature myopia, index myopia, and myopia caused by other syndromes such as Mafan's syndrome, Stifkler syndrome, etc. The cause of myopia is not related to the length of the eye axis 2. Simple myopia 3. Acute or chronic inflammation or tumors in the eyeball or surrounding tissues 4. Patients with suspected glaucoma or normal intraocular pressure glaucoma 5. Serious systemic diseases such as heart disease, leukemia, collagen disease, diabetes, nephrotic retinopathy, severe hypertension, etc.

Design outcomes

Primary

Measure	Time frame
Best corrected visual acuity, BCVA ;Length of ocular ;Complication ;	—

Countries

China

Contacts

Public ContactLei Jiang

Shijiazhuang Aiyan Ophthalmology Hospital

hhgdoughnut@163.com+86 136 0339 8205

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026